Ajax-Loading

Eli Lilly and Company - Minority Interest Expense

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Minority-Interest-Expense" stands at -0.2191 Billion United States Dollars for the trailing twelve months (TTM) period ending 03/31/2022, the highest value since 06/30/2018.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.5133 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.5133 Billion United States Dollars.
The 3 year change is 2.09 Billion United States Dollars.
The 5 year change is -0.0736 Billion United States Dollars.

The Serie's long term average value is -0.516 Billion United States Dollars. It's latest available value, on 03/31/2022, is 0.296 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 06/30/2019, to it's latest available value, on 03/31/2022, is +2.10 Billion.
The Serie's change in United States Dollars from it's maximum value, on 06/30/2017, to it's latest available value, on 03/31/2022, is -0.3871 Billion.

Minority Interest Expense for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Minority Interest Expense486,508,953,600.00
LogoAbbVie Inc - Minority Interest Expense399,570,305,024.00
LogoRoche Holding AG - Minority Interest Expense317,433,206,677.55
LogoAstraZeneca PLC - Minority Interest Expense280,205,508,085.11
LogoNovartis AG - Minority Interest Expense255,096,620,580.91